Paclitaxel-carboplatin-gemcitabine (TCG) versus paclitaxel-carboplatin (TC) as first line treatment in women with ovarian cancer: A randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102)

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ أكثر حفظ في قائمتي

المؤلفون: Belau, AK; Huober, J; Heilmann, V; Mueller, HH; Burges, A; Pfisterer, J; Gropp, M; Schröder, W; Wimberger, P; du Bois, A
المصدر:
27. Deutscher Krebskongress; 20060322-20060326; Berlin; DOCOP341 /20060320/
الموضوع:
ddc: 610
نوع التسجيلة:
conference object
اللغة:
English